PORKEROpen the app

House bill · 119th Congress · Latest step: Introduced

Protecting Consumer Access to Generic Drugs Act of 2026

H.R. 10887Introduced Oct 22, 2026Policy area: Health

Official title: To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.

Sponsor: Rep. Seth Magaziner D-RI
Open in Bill Explorer →

Where it went

Latest action: Oct 22, 2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cost and committee reports

Official records Congress.gov attaches to H.R. 10887.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of October 23, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 10887, last updated October 23, 2026. PORKER’s copy was retrieved October 23, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.

Vote results

No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).

Cosponsors

No cosponsors.

More from the sponsor

Other 119th Congress bills sponsored by Rep. Seth Magaziner.

Sponsor’s state and district

Rhode Island in Congress · RI-2 district

Open in Bill Explorer →

Data as of Oct 23, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.